Works matching IS 0195668X AND DT 2020 AND VI 41 AND IP 40
Results: 24
Dyslipidaemias and cardiovascular diseases: beyond cholesterol and atherosclerotic plaques.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3865, doi. 10.1093/eurheartj/ehaa889
- By:
- Publication type:
- Article
Erratum to: The PROFID project.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3948, doi. 10.1093/eurheartj/ehaa876
- Publication type:
- Article
The European Heart Journal – Digital Health.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3871, doi. 10.1093/eurheartj/ehaa838
- By:
- Publication type:
- Article
Low-Dose Edoxaban for Stroke Prevention in Elderly Patients with Atrial Fibrillation: Comment on the Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients (ELDERCARE-AF) Trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3882, doi. 10.1093/eurheartj/ehaa836
- By:
- Publication type:
- Article
Advancing RNA-targeted therapy for personalised prevention of coronary disease: focus on ANGPLT3.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3946, doi. 10.1093/eurheartj/ehaa790
- By:
- Publication type:
- Article
ESC Congress 2020 - Young Investigator Awards.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3873, doi. 10.1093/eurheartj/ehaa787
- By:
- Publication type:
- Article
EMPEROR-Reduced supports the use of SGLT2 inhibitors for the treatment of patients with heart failure and reduced ejection fraction: Comment on the EMPEROR-Reduced trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3881, doi. 10.1093/eurheartj/ehaa783
- By:
- Publication type:
- Article
Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3880, doi. 10.1093/eurheartj/ehaa782
- By:
- Publication type:
- Article
Can EPA evaporate plaques?
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3933, doi. 10.1093/eurheartj/ehaa750
- By:
- Publication type:
- Article
The obesity paradigm in cardiovascular disease: the need for differentiated weight management.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3965, doi. 10.1093/eurheartj/ehaa724
- By:
- Publication type:
- Article
Life course explains the 'obesity paradox'?
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3963, doi. 10.1093/eurheartj/ehaa717
- By:
- Publication type:
- Article
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3936, doi. 10.1093/eurheartj/ehaa689
- By:
- Publication type:
- Article
The new Dyslipidaemia Team of the European Heart Journal.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3870, doi. 10.1093/eurheartj/ehaa680
- By:
- Publication type:
- Article
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3925, doi. 10.1093/eurheartj/ehaa652
- By:
- Publication type:
- Article
COVID-19 pandemic in India.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3874, doi. 10.1093/eurheartj/ehaa493
- By:
- Publication type:
- Article
Czech Republic and low COVID-19 mortality in the heart of Europe: possible explanations.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3876, doi. 10.1093/eurheartj/ehaa465
- By:
- Publication type:
- Article
Percutaneous closure of right coronary artery to the left ventricle coronary cameral fistula in a case of congenitally absent left coronary artery.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3966, doi. 10.1093/eurheartj/ehaa364
- By:
- Publication type:
- Article
From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3884, doi. 10.1093/eurheartj/ehaa229
- By:
- Publication type:
- Article
Lipid levels linked to symptomatic aortic valve stenosis: evidence from Mendelian randomization?
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3921, doi. 10.1093/eurheartj/ehaa225
- By:
- Publication type:
- Article
Role of homeostatic iron regulator protein in hepatic cholesterol metabolism: interaction between Kupffer cells and hepatocytes?
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3960, doi. 10.1093/eurheartj/ehaa178
- By:
- Publication type:
- Article
The haemochromatosis gene Hfe and Kupffer cells control LDL cholesterol homeostasis and impact on atherosclerosis development.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3949, doi. 10.1093/eurheartj/ehaa140
- By:
- Publication type:
- Article
Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB?
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3910, doi. 10.1093/eurheartj/ehaa139
- By:
- Publication type:
- Article
Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3913, doi. 10.1093/eurheartj/ehaa070
- By:
- Publication type:
- Article
Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study.
- Published in:
- European Heart Journal, 2020, v. 41, n. 40, p. 3900, doi. 10.1093/eurheartj/ehaa034
- By:
- Publication type:
- Article